首页 | 官方网站   微博 | 高级检索  
     


Improvement of Aglycone π-Stacking Yields Nanomolar to Sub-nanomolar FimH Antagonists
Authors:Dr Wojciech Schönemann  Dr Jonathan Cramer  Tobias Mühlethaler  Dr Brigitte Fiege  Marleen Silbermann  Dr Said Rabbani  Dr Philipp Dätwyler  Dr Pascal Zihlmann  Dr Roman P Jakob  Dr Christoph P Sager  Dr Martin Smie?ko  Dr Oliver Schwardt  Prof?Dr Timm Maier  Prof?Dr Beat Ernst
Affiliation:1. Department of Pharmaceutical Sciences, University of Basel, Klingelbergstrasse 50, 4056 Basel, Switzerland;2. Department Biozentrum, Focal Area Structural Biology, University of Basel, Klingelbergstrasse 70, 4056 Basel, Switzerland
Abstract:Antimicrobial resistance has become a serious concern for the treatment of urinary tract infections. In this context, an anti-adhesive approach targeting FimH, a bacterial lectin enabling the attachment of E. coli to host cells, has attracted considerable interest. FimH can adopt a low/medium-affinity state in the absence and a high-affinity state in the presence of shear forces. Until recently, mostly the high-affinity state has been investigated, despite the fact that a therapeutic antagonist should bind predominantly to the low-affinity state. In this communication, we demonstrate that fluorination of biphenyl α-d -mannosides leads to compounds with perfect π–π stacking interactions with the tyrosine gate of FimH, yielding low nanomolar to sub-nanomolar KD values for the low- and high-affinity states, respectively. The face-to-face alignment of the perfluorinated biphenyl group of FimH ligands and Tyr48 was confirmed by crystal structures as well as 1H,15N-HSQC NMR analysis. Finally, fluorination improves pharmacokinetic parameters predictive for oral availability.
Keywords:antibiotics  drug design  FimH antagonists  urinary tract infections  uropathogenic Escherichia coli
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号